Treatment of resectable stage IIIA non-small cell lung cancer

被引:0
|
作者
Cardenal, Felipe [1 ]
Palmero, Ramon [1 ]
机构
[1] Hosp Duran Reynals, Catalan Inst Oncol, Dept Med Oncol, Avgda Granvia 199 203,LHospitalet Llobregat, Barcelona 08908, Spain
关键词
RANDOMIZED CONTROLLED-TRIAL; PREOPERATIVE CHEMOTHERAPY; PHASE-III; NEOADJUVANT CHEMORADIOTHERAPY; CONCURRENT CHEMORADIOTHERAPY; INDUCTION TREATMENT; SURGICAL RESECTION; RADIOTHERAPY; SURGERY; N2;
D O I
10.21037/jtd.2017.01.08
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:13 / 15
页数:3
相关论文
共 50 条
  • [21] Thoroughness of Mediastinal Staging in Stage IIIA Non-small Cell Lung Cancer
    Vest, Michael T.
    Tanoue, Lynn
    Soulos, Pamela R.
    Kim, Anthony W.
    Detterbeck, Frank
    Morgensztern, Daniel
    Gross, Cary P.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (01) : 188 - 195
  • [22] Preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancer
    Ahn, YC
    Park, K
    Kim, DY
    Kim, KM
    Kim, J
    Shim, YM
    Lee, KS
    Han, JH
    Kim, HJ
    Kwon, OJ
    Lim, DH
    Noh, YJ
    Lee, JE
    Huh, SJ
    ACTA ONCOLOGICA, 2001, 40 (05) : 588 - 592
  • [23] Accuracy of Clinical Stage in Resectable Non-small Cell Lung Cancer (NSCLC)
    Gwon, H. R.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S520 - S521
  • [24] Sublobar resection for early-stage non-small cell lung cancer and current advances with immunotherapy in multimodality treatment of resectable non-small cell lung cancer
    Agrafiotis, Apostolos C.
    Hendriks, Jeroen M. H.
    Van Schil, Paul E.
    AME SURGICAL JOURNAL, 2024, 4
  • [25] Multidisciplinary treatment for stage IIIA non-small cell lung cancer (NSCLC): Does institution matter?
    Samson, Pamela Parker
    Patel, Aalok
    Crabtree, Traves
    Morgensztern, Daniel
    Robinson, Cliff Grant
    Colditz, Graham A.
    Waqar, Saiama Naheed
    Kreisel, Daniel
    Patterson, G. Alexander
    Krupnick, Alexander Sasha
    Broderick, Stephen R.
    Meyers, Bryan F.
    Purl, Varun
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] Evaluation of Treatment Strategies for Patients with Stage IIIA Non-Small Cell Lung Cancer in the Immunotherapy Era
    Alabaster, A.
    Velotta, J. B.
    Tupper, H. I.
    Natanzon, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S584 - S585
  • [27] Multidisciplinary Treatment for Stage IIIA Non-Small Cell Lung Cancer: Does Institution Type Matter?
    Samson, Pamela
    Patel, Aalok
    Crabtree, Traves D.
    Morgensztern, Daniel
    Robinson, Cliff G.
    Colditz, Graham A.
    Waqar, Saiama
    Kreisel, Daniel
    Krupnick, A. Sasha
    Patterson, G. Alexander
    Broderick, Stephen
    Meyers, Bryan F.
    Puri, Varun
    ANNALS OF THORACIC SURGERY, 2015, 100 (05): : 1773 - 1779
  • [28] Stage IIIA Non-Small Cell Lung Cancer Treatment and Outcomes: A Single Institution Retrospective Analysis
    Duan, R.
    Kwan, M.
    Kordon, A.
    Hu, C.
    Vanjani, N.
    Thomas, T. O.
    Patel, J. D.
    Yadav, P.
    Abazeed, M.
    Gharzai, L. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E16 - E16
  • [30] Role of radiotherapy in the treatment of stage IIIA/pN2 non-small cell lung cancer
    Kaesmann, L.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S263 - S263